Title |
Correction: Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study |
|---|---|
Involved |
Thomas Martin (Verfasser)
Meletios A. Dimopoulos (Verfasser) Joseph Mikhael (Verfasser) Kwee Yong (Verfasser)
Marcelo Capra (Verfasser)
Thierry Facon (Verfasser) Roman Hájek (Verfasser) Ivan Špička (Verfasser) Ross Baker (Verfasser) Kihyun Kim (Verfasser) Gracia Martinez (Verfasser) Chang-Ki Min (Verfasser) Ludek Pour (Verfasser) Xavier Leleu (Verfasser) Albert Oriol (Verfasser) Youngil Koh (Verfasser) Kenshi Suzuki (Verfasser) France Casca (Verfasser) Sandrine Macé (Verfasser) Marie-Laure Risse (Verfasser) Philippe Moreau (Verfasser) SpringerLink (Online service) (Sonstige) |
Published in |
Blood cancer journal 13, 1, 27.9.2023, date:12.2023, Seite 1 |
Published |
2023 |
Language |
|
Country |
|
Topic |
|
Subject |
Biomedical Research. |
DDC notation |
|
Persistent identifier |
urn:nbn:de:101:1-2024013114324901503177 (URN) |
Record ID |
1317844165 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: